Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
3.160
USD
-0.235 (-6.92%)
Official Closing Price
Updated: 7:50 PM EST, Mar 4, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Biotechs Seek Advancements In The Immuno-Oncology Field For Childhood Brain Tumors
November 12, 2019
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs Seek Advancements in the Immuno-Oncology Field for Childhood Brain Tumors
November 12, 2019
Financialnewsmedia.com News Commentary
From
PR Newswire
The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat
November 12, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
KDMN
TELA
OCGN
From
Benzinga
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
November 11, 2019
UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of uro-oncology, today announced that it has entered into an...
From
Business Wire News Releases
Agenus receives $10M from UroGen Pharma for rights to Zalifrelimab (CTLA-4) for intravesical treatment of urinary tract cancers
November 11, 2019
- UroGen receives rights to zalifrelimab to be used in its proprietary sustained release formulation for patients with high-grade non-muscle invasive bladder cancer
From
PR Newswire
The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut
November 08, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
XOMA
PLXP
HSDT
From
Benzinga
Are These Penny Stocks a Buy Or Sell?
November 07, 2019
3 Penny Stocks to Watch in November When it comes to penny…
From
Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Global Nanotechnology And Nanomedicine Treatment Markets Could Reach $350 Billion By 2025
November 07, 2019
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Nanotechnology and Nanomedicine Treatment Markets Could Reach $350 Billion by 2025
November 07, 2019
Financialnewsmedia.com News Commentary
From
PR Newswire
Noteworthy Wednesday Option Activity: AGEN, ECOL, SONO
November 06, 2019
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Agenus Inc (AGEN), where a total of 12,720 contracts have traded so far, representing...
Tags
Stocks
From
Market News Video
Analysts Anticipate 21% Upside For IEIH
November 05, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Agenus Inc (AGEN) Q3 2019 Earnings Call Transcript
November 04, 2019
AGEN earnings call for the period ending September 30, 2019.
Tags
Market News
AGEN
From
Motley Fool
Agenus Provides Corporate Update with Third Quarter 2019 Financial Results
November 04, 2019
- PD-1 plus CTLA-4 cervical trial completes planned accrual & planned interim analysis
From
PR Newswire
Agenus to Report Third Quarter 2019 Financial Results on November 4, 2019 and Host Conference Call and Webcast
October 31, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its third quarter 2019 financial results before the market opens...
From
PR Newswire
3 Cancer Treatment Stocks to Buy Right Now
October 10, 2019
These three beaten-down cancer stocks could prove to be amazing value plays.
Tags
PBYI
AGEN
Market News
From
Motley Fool
Patients Turn to Assistance Programs for Aid in the Fight Against Chronic Diseases
October 04, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
IEIH's Holdings Could Mean 28% Gain Potential
October 02, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Biotechs Endeavour to Increase Access to Cancer Treatments
October 01, 2019
FinancialBuzz.com News Commentary
From
PR Newswire
Agenus to Present at the 2019 Cantor Global Healthcare Conference on October 4, 2019
September 30, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, adoptive cell therapies1 and cancer vaccines, announced today that Jennifer Buell, PhD,...
From
PR Newswire
VBI Vaccines Announces Phase 2a Clinical Evaluation of VBI-1901 Cancer Vaccine Candidate in Combination with GSK’s AS01B Adjuvant System in Recurrent Glioblastoma Patients
September 10, 2019
VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with...
From
Business Wire News Releases
The Implied Analyst 12-Month Target For IEIH
August 27, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Commit To Purchase Agenus At $2, Earn 9.9% Annualized Using Options
August 20, 2019
Investors considering a purchase of Agenus Inc (AGEN) shares, but tentative about paying the going market price of $2.83/share, might benefit from considering selling puts among the alternative...
Tags
Stocks
From
Market News Video
Agenus Inc (AGEN) Q2 2019 Earnings Call Transcript
August 10, 2019
AGEN earnings call for the period ending June 30, 2019.
Tags
AGEN
Market News
From
Motley Fool
110 Biggest Movers From Yesterday
August 09, 2019
Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) climbed 76.5% to close at $4.27 on Thursday after the company agreed to be ...
Tags
VERI
GTS
NTRA
From
Benzinga
90 Stocks Moving In Thursday's Mid-Day Session
August 08, 2019
Gainers Corindus Vascular Robotics, Inc. (NYSE: CVRS) surged 75.6% to $4.25 after the company agreed to be acquired by Siemens ...
Tags
FTDR
VSTO
Trading Ideas
From
Benzinga
Agenus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
August 08, 2019
- Enrollment of CTLA-4 & PD-1 trials on track; data expected 2H2019
From
PR Newswire
Agenus Milestone Triggers $7.5M Payment
August 08, 2019
- FDA acceptance of IND filing for AGEN2373 triggers payment and clears path to begin clinical trials
From
PR Newswire
Agenus to Report Second Quarter 2019 Financial Results on August 8, 2019 and Host Conference Call and Webcast
August 06, 2019
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies and cancer vaccines, will release its second quarter 2019 financial results before the market...
From
PR Newswire
33 Healthcare Stocks Moving In Today's Pre-Market Session
July 30, 2019
Gainers Valeritas Holdings, Inc. (NASDAQ: VLRX) stock rose 15.2% today to $2.88 during Tuesday's pre-market session. The ...
Tags
THC
Trading Ideas
MOR
From
Benzinga
Agenus Appoints Don Vidic as Vice President and Head of Commercial
July 18, 2019
The appointment comes as Agenus is preparing for its first BLA filing in 2020 and evolving towards a commercial company
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.